Summary of descriptive characteristics of included studies evaluating health insurance coverage (n = 33)
| Author (year) . | Data source years . | US region . | Patients N . | Outcome/analysis . | Cohorts . | HR (95% CI) . | Social determinant associated with worse survival . |
|---|---|---|---|---|---|---|---|
| Yung et al,19 (2011) | NYSCR 2001–2008 | NY | HL 4752 | OS/multi | Non-Medicaid Medicaid | Ref. 1.98 (1.47-2.68)∗ | Medicaid |
| CCR 2000–2007 | CA | HL 4752 | OS/multi | Non-Medicaid Medicaid | Ref. 1.89 (1.43-2.49)∗ | Medicaid | |
| Parikh et al,39 (2015) | NCDB 1998-2011 | National | HL 45 777 | OS/multi | Uninsured Private Medicaid Medicare | Ref. 0.58 (0.49-0.69)∗, 1.60 (1.34-1.91)∗ 1.05 (0.70-1.60) | Uninsured and Medicaid |
| Abodunrin (2022) | SEER 2007-2015 | National | NHL 44 609 | OS/multi | Private Public Uninsured | Ref. 2.11 (2.00-2.24)∗, 1.76 (1.62-1.91)∗ | Public insurance and uninsured |
| Goldstein et al,21 (2019) | NCDB 2004-2014 | National | NHL <65 y.o. 22 133 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.96 (1.69-2.28)∗, 1.83 (1.57-2.12)∗, 1.96 (1.71-2.24)∗ | Uninsured, Medicaid, and Medicare |
| NHL. ≥65 y.o. 21 515 | OS/multi | Private Medicare | Ref. 1.28 (1.17-1.4)∗ | Medicare | |||
| Dhakal et al,22 (2019) | NCDB 2006-2012 | National | NHL 132 402 | 1-month mortality/multi | Private Medicaid Medicare Uninsured | Ref. 1.60 (1.34-1.92)∗, 1.75 (1.57-1.94)∗, 1.77 (1.43-2.19)∗ | Medicaid, Medicare, and uninsured |
| OS/multi | Private Medicaid Medicare Uninsured Other government | Ref. 1.61 (1.53-1.70)∗, 1.66 (1.61-1.71)∗, 1.44 (1.35-1.54)∗, 1.29 (1.17-1.43)∗ | Medicaid, Medicare, uninsured, and other government insurance | ||||
| Go (2016) | NCDB 1998-2011 | National | NHL 278 985 | OS/multi | Private Medicare Medicaid Government Uninsured | Ref. 1.66 (1.64-1.69)†, 1.74 (1.70-1.79)†, 1.16 (1.07-1.25)†, 1.37 (1.34-1.40)† | Medicare, Medicaid, government insurance, and uninsured |
| Han (2014) | NCDB 2004-2010 | National | NHL 3858 | OS/multi | Private Uninsured Medicaid | Ref. 1.18 (0.96-1.44) 1.27 (1.06-1.53)† | Medicaid |
| Shah (2019) | NCDB 2004-2013 | National | NHL 18 120 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.44 (1.22-1.70)∗, 1.33 (1.15-1.54)∗ 1.05 (0.98-1.13) | Uninsured and Medicaid |
| Tao et al,25 (2014) | CCR 2001-2009 | CA | NHL | CSS/multi | Private/military Public/uninsured | Ref. 1.46 (1.30-1.63)∗ | Public insurance or uninsured |
| 16 133 | OS/multi | Private/military Public/uninsured | Ref. 1.54 (1.40-1.69)∗ | Public insurance or uninsured | |||
| Ermann (2020) | NCDB 2004-2015 | National | NHL 27 690 | OS/multi | Uninsured Private Medicaid Medicare | Ref. 0.71 (NS)∗, 1.25 (NS)∗, 1.76 (NS)∗ | Uninsured, Medicaid, and Medicare |
| Goldstein et al,21 (2019) | NCDB 2004–2014 | National | NHL aged <65 y.o. 314 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 0.85 (0.4-1.6) 0.78 (0.5-1.2) 1.2 (0.7-2.1) | - |
| NH aged ≥65 161 | OS/multi | Private Medicaid Medicare | Ref. 1.49 (0.1-14.8) 1.34 (0.4-4.3) | - | |||
| Chohan et al,18 (2022) | NCDB 2004-2017 | National | WM <65 y.o. 1249 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 3.11 (1.77-5.45)∗, 1.88 (1.01-3.48)∗, 2.78 (1.76-4.38)∗ | Uninsured, Medicare, and Medicaid |
| WM ≥65 y.o. 2629 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 0.25 (0.03-1.77) 1.05 (0.45-2.43) 1.08 (0.85-1.36) | - | |||
| Gunaratne et al,35 (2021) | NCBD 2004-2014 | National | WM 3064 | OS/multi | Private Government Uninsured | Ref. 1.31 (1.07-1.59)∗ 1.50 (0.91-1.47) | Government insurance |
| Goldstein et al,21 (2019) | NCDB 2004–2014 | National | BL < 65 y.o. 5235 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.44 (1.2-1.7)∗, 1.22 (1.0-1.4)∗, 1.53 (1.2-1.9)∗ | Uninsured, Medicaid, and Medicare |
| BL ≥ 65 y.o. 1838 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 8.38 (2.5-28.3)∗ 0.75 (0.3-1.8) 1.29 (0.9-1.8) | Uninsured | |||
| Fiala et al,15 (2015) | Institutional 2000-2009 | MO | MM 652 | OS/Uni | Private Medicare Medicaid Uninsured | 67.5 mo 37.5 mo∗, 38.3 mo∗, 59.0 mo∗ | Uninsured, Medicaid, and Medicare |
| OS/multi | Private Medicare Medicaid Uninsured | Ref. 0.74 (0.53-1.03) 1.22 (0.70-2.14) 1.59 (0.94-2.70) | - | ||||
| Makhani (2021) | SEER 2007-2016 | National | MM. 41 789 | CSS/multi | Private Uninsured Medicaid Insurance | Ref. 1.26 (1.11-1.42)∗, 1.44 (1.36-1.53)∗ 1.11 (1.06-1.17) | Medicaid and uninsured |
| Jayakrishnan (2021) | NCDB 2004-2016 | National | MM 50 543 | OS/multi | Uninsured Private Medicaid Medicare | Ref. 0.83 (0.78-0.89)∗, 1.09 (1.01-1.17)∗, 0.90 (0.84-0.96)∗ | Uninsured and Medicaid |
| Ho et al,24 (2017) | CCR 1999-2012 | CA | MM 6359 | 60-day mortality | Private Medicare Public Uninsured | Ref. 1.07 (0.88-1.30) 1.08 (0.81-1.44) 2.44 (1.45-4.13)∗ | Uninsured |
| Chamoun (2021) | NCDB 2005-2014 | National | MM 117 926 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.62 (1.32-1.99)∗, 1.59 (1.36-1.87)∗ 1.09 (0.99-1.2) | Medicaid and uninsured |
| Huang et al,31 (2021) | SEER 2007-2016 | National | MM 17 981 | CSS/multi | Insured Uninsured Medicaid | Ref. 1.13 (1.00-1.28)∗, 1.25 (1.16-1.36)∗ | Uninsured and Medicaid |
| OS/multi | Insured Uninsured Medicaid | Ref. 1.33 (1.20-1.48)∗, 1.67 (1.56-1.78)∗ | Uninsured and Medicaid | ||||
| Costa et al,37 (2016) | SEER 2007-2012 | National | MM 10 161 | 12-month mortality | Insured Medicaid Uninsured | Ref. 2.04 (1.74-2.41)∗, 1.72 (1.34-2.19)∗ | Medicaid and uninsured |
| OS/multi | Insured Medicaid Uninsured | Ref. 1.76 (1.59-1.94)∗, 1.43 (1.23-1.67)∗ | Medicaid and uninsured | ||||
| Ghiassi-Nejad et al,23 (2019) | NCDB 2004-2013 | National | PM P-bone 4056 | OS/Multi. | Uninsured Private Government | Ref. 0.70 (0.48-0.98)∗ 1.02 (0.72-1.46) | Uninsured |
| PM P-EM 1468 | OS/multi | Uninsured Private Government | Ref. 0.44 (0.26-0.73)∗ 0.64 (0.37-1.09) | Uninsured | |||
| Yung et al,19 (2011) | NYSCR 2001–2008 | NY | AML 3506 | OS/multi | Non-Medicaid Medicaid | Ref. 1.00 (0.84-1.19) | - |
| CCR 2000–2007 | CA | AML 3506 | OS/multi | Non-Medicaid Medicaid | Ref. 1.02 (0.89-1.16) | - | |
| Bhatt (2017) | NCDB 2003-2011 | National | AML 60 738 | 1-month mortality/multi | Private Uninsured Medicaid Medicare | Ref. 2.02 (1.80-2.27)∗, 1.05 (0.94-1.16) 1.29 (1.21-1.37)∗ | Uninsured and Medicare |
| OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.18 (1.12-1.25)∗, 1.11 (1.07-1.16)∗, 1.20 (1.17-1.23)∗ | Uninsured, Medicaid, and Medicare | ||||
| Byrne et al,35 (2011) | FCDS 1998-2002 | FL | AML 4659 | OS/multi | Private Uninsured Medicare Medicaid | Ref. 1.08 (0.83-1.39) 0.97 (0.87-1.07) 1.25 (1.06-1.47)∗ | Medicaid |
| Freeman et al,32 (2016) | NC CCR 2003-2009 | NC | AML 900 | OS/multi | Private Medicare Medicaid | Ref. 0.91 (0.71-1.17) 1.36 (1.00-1.85)∗ | Medicaid |
| Borate et al,38 (2015) | SEER 2007-2011 | National | AML 5541 | 2-month mortality | Insured Medicaid Uninsured | Ref. OR. 1.34 (1.07-1.66)∗, 1.99 (1.46-2.73)∗ | Medicaid and uninsured |
| OS/multi | Insured Medicaid Uninsured | Ref. 1.24 (1.13-1.37)∗, 1.24 (1.07-1.44)∗ | Medicaid and uninsured | ||||
| Bradley et al,34 (2011) | VCR/VHI 1999-2006 | VA | AML No CTX NS | OS/multi | Private/military Uninsured Public | Ref. 1.29 (1.02-1.84)∗, 1.39 (1.02-1.88)∗ | Uninsured and public |
| AML CTX NS | OS/multi | Private/military Uninsured Public | Ref. 1.07 (0.74-1.54) 1.31 (0.96-1.77) | - | |||
| Master et al,28 (2016) | NCDB 1998-2012 | National | AML 67 443 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.20 (1.14-1.27)∗, 1.16 (1.12-1.22)∗, 1.19 (1.15-1.23)∗ | Medicaid, uninsured and Medicare |
| Al-Ameri et al,20 (2014) | Institutional 2002-2010 | OH | AML/MDS 94 | OS/multi | Private Medicaid/Medicare Medicare with suppl. | Ref. 0.61 (0.33-1.13) 0.93 (0.49-1.76) | - |
| Dhakal et al,17 (2022) | NCDB 2004-2015 | National | APL < 65 y.o. 5380 | 1-month mortality | Private Medicaid Medicare Uninsured | Ref. 1.14 (0.86-1.51) 1.78 (1.29-2.47)∗, 2.31 (1.61-3.32)∗ | Medicare and uninsured |
| APL ≥ 65 y.o. 1520 | 1-month mortality | Private Nonprivate | Ref. 1.16 (0.76-1.77) | - | |||
| APL < 65 y.o. 5380 | OS/multi | Private Medicaid Medicare Uninsured | Ref. 1.40 (1.19-1.64)∗, 1.89 (1.58-2.26)∗ 1.24 (0.96-1.60) | Medicaid and Medicare | |||
| APL ≥ 65 y.o. 1520 | OS/multi | Private Nonprivate | Ref. 0.86-1.33 | - | |||
| Krakora (2020) | Institutional 2007-2017 | NJ | ALL 136 | PFS/multi | Insured Uninsured | Ref. 3.31 (1.53-7.17)∗ | Uninsured |
| OS/multi | Insured Uninsured | Ref. 1.84 (0.92-3.66) | - | ||||
| Perry et al,16 (2017) | SEER 2007-2012 | National | CML 15-64 y.o. 3626 | OS/multi | Insured Medicaid Uninsured | Ref. 1.83 (1.39-2.40)∗, 1.93 (1.40-2.66)∗ | Uninsured or Medicaid |
| CML ≥ 65 y.o. 2142 | OS/multi | Insured Medicaid | Ref. 1.26 (1.00-1.64) | - |
| Author (year) . | Data source years . | US region . | Patients N . | Outcome/analysis . | Cohorts . | HR (95% CI) . | Social determinant associated with worse survival . |
|---|---|---|---|---|---|---|---|
| Yung et al,19 (2011) | NYSCR 2001–2008 | NY | HL 4752 | OS/multi | Non-Medicaid Medicaid | Ref. 1.98 (1.47-2.68)∗ | Medicaid |
| CCR 2000–2007 | CA | HL 4752 | OS/multi | Non-Medicaid Medicaid | Ref. 1.89 (1.43-2.49)∗ | Medicaid | |
| Parikh et al,39 (2015) | NCDB 1998-2011 | National | HL 45 777 | OS/multi | Uninsured Private Medicaid Medicare | Ref. 0.58 (0.49-0.69)∗, 1.60 (1.34-1.91)∗ 1.05 (0.70-1.60) | Uninsured and Medicaid |
| Abodunrin (2022) | SEER 2007-2015 | National | NHL 44 609 | OS/multi | Private Public Uninsured | Ref. 2.11 (2.00-2.24)∗, 1.76 (1.62-1.91)∗ | Public insurance and uninsured |
| Goldstein et al,21 (2019) | NCDB 2004-2014 | National | NHL <65 y.o. 22 133 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.96 (1.69-2.28)∗, 1.83 (1.57-2.12)∗, 1.96 (1.71-2.24)∗ | Uninsured, Medicaid, and Medicare |
| NHL. ≥65 y.o. 21 515 | OS/multi | Private Medicare | Ref. 1.28 (1.17-1.4)∗ | Medicare | |||
| Dhakal et al,22 (2019) | NCDB 2006-2012 | National | NHL 132 402 | 1-month mortality/multi | Private Medicaid Medicare Uninsured | Ref. 1.60 (1.34-1.92)∗, 1.75 (1.57-1.94)∗, 1.77 (1.43-2.19)∗ | Medicaid, Medicare, and uninsured |
| OS/multi | Private Medicaid Medicare Uninsured Other government | Ref. 1.61 (1.53-1.70)∗, 1.66 (1.61-1.71)∗, 1.44 (1.35-1.54)∗, 1.29 (1.17-1.43)∗ | Medicaid, Medicare, uninsured, and other government insurance | ||||
| Go (2016) | NCDB 1998-2011 | National | NHL 278 985 | OS/multi | Private Medicare Medicaid Government Uninsured | Ref. 1.66 (1.64-1.69)†, 1.74 (1.70-1.79)†, 1.16 (1.07-1.25)†, 1.37 (1.34-1.40)† | Medicare, Medicaid, government insurance, and uninsured |
| Han (2014) | NCDB 2004-2010 | National | NHL 3858 | OS/multi | Private Uninsured Medicaid | Ref. 1.18 (0.96-1.44) 1.27 (1.06-1.53)† | Medicaid |
| Shah (2019) | NCDB 2004-2013 | National | NHL 18 120 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.44 (1.22-1.70)∗, 1.33 (1.15-1.54)∗ 1.05 (0.98-1.13) | Uninsured and Medicaid |
| Tao et al,25 (2014) | CCR 2001-2009 | CA | NHL | CSS/multi | Private/military Public/uninsured | Ref. 1.46 (1.30-1.63)∗ | Public insurance or uninsured |
| 16 133 | OS/multi | Private/military Public/uninsured | Ref. 1.54 (1.40-1.69)∗ | Public insurance or uninsured | |||
| Ermann (2020) | NCDB 2004-2015 | National | NHL 27 690 | OS/multi | Uninsured Private Medicaid Medicare | Ref. 0.71 (NS)∗, 1.25 (NS)∗, 1.76 (NS)∗ | Uninsured, Medicaid, and Medicare |
| Goldstein et al,21 (2019) | NCDB 2004–2014 | National | NHL aged <65 y.o. 314 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 0.85 (0.4-1.6) 0.78 (0.5-1.2) 1.2 (0.7-2.1) | - |
| NH aged ≥65 161 | OS/multi | Private Medicaid Medicare | Ref. 1.49 (0.1-14.8) 1.34 (0.4-4.3) | - | |||
| Chohan et al,18 (2022) | NCDB 2004-2017 | National | WM <65 y.o. 1249 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 3.11 (1.77-5.45)∗, 1.88 (1.01-3.48)∗, 2.78 (1.76-4.38)∗ | Uninsured, Medicare, and Medicaid |
| WM ≥65 y.o. 2629 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 0.25 (0.03-1.77) 1.05 (0.45-2.43) 1.08 (0.85-1.36) | - | |||
| Gunaratne et al,35 (2021) | NCBD 2004-2014 | National | WM 3064 | OS/multi | Private Government Uninsured | Ref. 1.31 (1.07-1.59)∗ 1.50 (0.91-1.47) | Government insurance |
| Goldstein et al,21 (2019) | NCDB 2004–2014 | National | BL < 65 y.o. 5235 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.44 (1.2-1.7)∗, 1.22 (1.0-1.4)∗, 1.53 (1.2-1.9)∗ | Uninsured, Medicaid, and Medicare |
| BL ≥ 65 y.o. 1838 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 8.38 (2.5-28.3)∗ 0.75 (0.3-1.8) 1.29 (0.9-1.8) | Uninsured | |||
| Fiala et al,15 (2015) | Institutional 2000-2009 | MO | MM 652 | OS/Uni | Private Medicare Medicaid Uninsured | 67.5 mo 37.5 mo∗, 38.3 mo∗, 59.0 mo∗ | Uninsured, Medicaid, and Medicare |
| OS/multi | Private Medicare Medicaid Uninsured | Ref. 0.74 (0.53-1.03) 1.22 (0.70-2.14) 1.59 (0.94-2.70) | - | ||||
| Makhani (2021) | SEER 2007-2016 | National | MM. 41 789 | CSS/multi | Private Uninsured Medicaid Insurance | Ref. 1.26 (1.11-1.42)∗, 1.44 (1.36-1.53)∗ 1.11 (1.06-1.17) | Medicaid and uninsured |
| Jayakrishnan (2021) | NCDB 2004-2016 | National | MM 50 543 | OS/multi | Uninsured Private Medicaid Medicare | Ref. 0.83 (0.78-0.89)∗, 1.09 (1.01-1.17)∗, 0.90 (0.84-0.96)∗ | Uninsured and Medicaid |
| Ho et al,24 (2017) | CCR 1999-2012 | CA | MM 6359 | 60-day mortality | Private Medicare Public Uninsured | Ref. 1.07 (0.88-1.30) 1.08 (0.81-1.44) 2.44 (1.45-4.13)∗ | Uninsured |
| Chamoun (2021) | NCDB 2005-2014 | National | MM 117 926 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.62 (1.32-1.99)∗, 1.59 (1.36-1.87)∗ 1.09 (0.99-1.2) | Medicaid and uninsured |
| Huang et al,31 (2021) | SEER 2007-2016 | National | MM 17 981 | CSS/multi | Insured Uninsured Medicaid | Ref. 1.13 (1.00-1.28)∗, 1.25 (1.16-1.36)∗ | Uninsured and Medicaid |
| OS/multi | Insured Uninsured Medicaid | Ref. 1.33 (1.20-1.48)∗, 1.67 (1.56-1.78)∗ | Uninsured and Medicaid | ||||
| Costa et al,37 (2016) | SEER 2007-2012 | National | MM 10 161 | 12-month mortality | Insured Medicaid Uninsured | Ref. 2.04 (1.74-2.41)∗, 1.72 (1.34-2.19)∗ | Medicaid and uninsured |
| OS/multi | Insured Medicaid Uninsured | Ref. 1.76 (1.59-1.94)∗, 1.43 (1.23-1.67)∗ | Medicaid and uninsured | ||||
| Ghiassi-Nejad et al,23 (2019) | NCDB 2004-2013 | National | PM P-bone 4056 | OS/Multi. | Uninsured Private Government | Ref. 0.70 (0.48-0.98)∗ 1.02 (0.72-1.46) | Uninsured |
| PM P-EM 1468 | OS/multi | Uninsured Private Government | Ref. 0.44 (0.26-0.73)∗ 0.64 (0.37-1.09) | Uninsured | |||
| Yung et al,19 (2011) | NYSCR 2001–2008 | NY | AML 3506 | OS/multi | Non-Medicaid Medicaid | Ref. 1.00 (0.84-1.19) | - |
| CCR 2000–2007 | CA | AML 3506 | OS/multi | Non-Medicaid Medicaid | Ref. 1.02 (0.89-1.16) | - | |
| Bhatt (2017) | NCDB 2003-2011 | National | AML 60 738 | 1-month mortality/multi | Private Uninsured Medicaid Medicare | Ref. 2.02 (1.80-2.27)∗, 1.05 (0.94-1.16) 1.29 (1.21-1.37)∗ | Uninsured and Medicare |
| OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.18 (1.12-1.25)∗, 1.11 (1.07-1.16)∗, 1.20 (1.17-1.23)∗ | Uninsured, Medicaid, and Medicare | ||||
| Byrne et al,35 (2011) | FCDS 1998-2002 | FL | AML 4659 | OS/multi | Private Uninsured Medicare Medicaid | Ref. 1.08 (0.83-1.39) 0.97 (0.87-1.07) 1.25 (1.06-1.47)∗ | Medicaid |
| Freeman et al,32 (2016) | NC CCR 2003-2009 | NC | AML 900 | OS/multi | Private Medicare Medicaid | Ref. 0.91 (0.71-1.17) 1.36 (1.00-1.85)∗ | Medicaid |
| Borate et al,38 (2015) | SEER 2007-2011 | National | AML 5541 | 2-month mortality | Insured Medicaid Uninsured | Ref. OR. 1.34 (1.07-1.66)∗, 1.99 (1.46-2.73)∗ | Medicaid and uninsured |
| OS/multi | Insured Medicaid Uninsured | Ref. 1.24 (1.13-1.37)∗, 1.24 (1.07-1.44)∗ | Medicaid and uninsured | ||||
| Bradley et al,34 (2011) | VCR/VHI 1999-2006 | VA | AML No CTX NS | OS/multi | Private/military Uninsured Public | Ref. 1.29 (1.02-1.84)∗, 1.39 (1.02-1.88)∗ | Uninsured and public |
| AML CTX NS | OS/multi | Private/military Uninsured Public | Ref. 1.07 (0.74-1.54) 1.31 (0.96-1.77) | - | |||
| Master et al,28 (2016) | NCDB 1998-2012 | National | AML 67 443 | OS/multi | Private Uninsured Medicaid Medicare | Ref. 1.20 (1.14-1.27)∗, 1.16 (1.12-1.22)∗, 1.19 (1.15-1.23)∗ | Medicaid, uninsured and Medicare |
| Al-Ameri et al,20 (2014) | Institutional 2002-2010 | OH | AML/MDS 94 | OS/multi | Private Medicaid/Medicare Medicare with suppl. | Ref. 0.61 (0.33-1.13) 0.93 (0.49-1.76) | - |
| Dhakal et al,17 (2022) | NCDB 2004-2015 | National | APL < 65 y.o. 5380 | 1-month mortality | Private Medicaid Medicare Uninsured | Ref. 1.14 (0.86-1.51) 1.78 (1.29-2.47)∗, 2.31 (1.61-3.32)∗ | Medicare and uninsured |
| APL ≥ 65 y.o. 1520 | 1-month mortality | Private Nonprivate | Ref. 1.16 (0.76-1.77) | - | |||
| APL < 65 y.o. 5380 | OS/multi | Private Medicaid Medicare Uninsured | Ref. 1.40 (1.19-1.64)∗, 1.89 (1.58-2.26)∗ 1.24 (0.96-1.60) | Medicaid and Medicare | |||
| APL ≥ 65 y.o. 1520 | OS/multi | Private Nonprivate | Ref. 0.86-1.33 | - | |||
| Krakora (2020) | Institutional 2007-2017 | NJ | ALL 136 | PFS/multi | Insured Uninsured | Ref. 3.31 (1.53-7.17)∗ | Uninsured |
| OS/multi | Insured Uninsured | Ref. 1.84 (0.92-3.66) | - | ||||
| Perry et al,16 (2017) | SEER 2007-2012 | National | CML 15-64 y.o. 3626 | OS/multi | Insured Medicaid Uninsured | Ref. 1.83 (1.39-2.40)∗, 1.93 (1.40-2.66)∗ | Uninsured or Medicaid |
| CML ≥ 65 y.o. 2142 | OS/multi | Insured Medicaid | Ref. 1.26 (1.00-1.64) | - |
AML, acute myeloid leukemia; APL, acute promyelocytic leukemia; BL, Burkitt lymphoma; CA, California; CCR, California Cancer Registry; CI, confidential interval; CML, chronic myeloid leukemia; CSS, cancer-specific survival; CTX, chemotherapy; FCDS, Florida Cancer Data System; FL, Florida; HL, Hodgkin lymphoma; HR, hazard ratio; MDS, myelodysplastic syndromes; MM, multiple myeloma; multi, multivariate analysis; N, sample size; NC, North Carolina; NC CCR, North Carolina Central Cancer Registry; NCDB, National Cancer Database; NHL, non-Hodgkin lymphoma; NJ, New Jersey; NOS, not otherwise specified; NS, not specified; NY, New York; NYSCR, New York State Cancer Registry; OH, Ohio; OR, odds ratio; P-bone, plasmacytoma originating in bone; P-EM, plasmacytoma originating in extramedullary; PFS, progression-free survival; PM, plasmacytoma; Ref., reference; SEER, Surveillance, Epidemiology, and End Results Registry; suppl., supplement; VA, Virginia; VCR, Virginia Cancer Registry; VHI, Virginia Health Information; WM, Waldenstrom macroglobulinemia; y.o., years old.
Reported as statistical significance by the author.
Statistical significance but not discussed by the author.